New study tracks hidden heart and bone risks in Cushing's disease
NCT ID NCT02568982
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study followed 80 people with newly diagnosed Cushing's disease for three years to see how the disease affects the heart, bones, metabolism, and quality of life. Researchers used blood tests, heart scans, bone density tests, and questionnaires to track complications before and after treatment. The goal is to better understand how these complications change over time and after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict and manage the long-term complications of Cushing's disease.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove that any specific therapy improves outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
80 people
The number who actually took part.
- Started
-
Sep 2015
- Finished
-
Dec 2019
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Cushing 's disease
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Cushing's disease diagnosed by complementary explorations according to the National Program of Diagnosis and Care of the Cushing 's disease Exclusion Criteria: * other cause of Cushing's syndrome * known inherited syndrome having for consequence an hormonal hypersecretion (NEM-1, complexe of carney, McCuneAlbright syndrome) * patient does not understand french * life expectancy of less than 6 months * pregnant women * dependent patient
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cushing's disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HP, Hôpital Cochin
Paris, Paris, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a stronger radiation dose fix hormone overload?
- New pill could tame hormone disorder Cushing's syndrome
- New scan could spot invisible brain tumors
- Virtual reality test reveals hidden memory damage in cured Cushing's patients
- Cushing's patients wanted for Long-Term health tracking study
- New scan could spot 'Invisible' brain tumors in Cushing's patients